2006
DOI: 10.1016/j.amjcard.2006.02.047
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Findings After Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
73
1
8

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 104 publications
(88 citation statements)
references
References 16 publications
6
73
1
8
Order By: Relevance
“…For example, aortic insufficiency developed de novo or worsened in 89% of patients at 12 years after performing hematopoietic stem cell transplantation at ~2 years [30] and in 60% of patients at 4-6 years after starting enzyme replacement therapy [31,32]. Although pathological data were not available, progressive fragmentation of the elastic fibers likely contributed to worsening aortic valve function.…”
Section: Discussionmentioning
confidence: 99%
“…For example, aortic insufficiency developed de novo or worsened in 89% of patients at 12 years after performing hematopoietic stem cell transplantation at ~2 years [30] and in 60% of patients at 4-6 years after starting enzyme replacement therapy [31,32]. Although pathological data were not available, progressive fragmentation of the elastic fibers likely contributed to worsening aortic valve function.…”
Section: Discussionmentioning
confidence: 99%
“…O miocĂĄrdio geralmente sofre hipertrofia, as vĂĄlvulas cardĂ­acas ficam espessadas e levam ao regurgitamento ou estenose, assim como, surgem alteraçÔes de grandes vasos, na qual a aorta apresenta a tĂșnica Ă­ntima acentuadamente espessada e por vezes sĂŁo vistas cĂ©lulas "claras" nas trĂȘs tĂșnicas, Ă  histopatologia (Wang et al, 2011;Braunlin et al, 2006). No presente estudo notou-se o espessamento acentuado da tĂșnica Ă­ntima e presença de aspecto de cĂ©lulas "claras" da aorta, que corresponde a cĂ©lulas vacuolizadas.…”
Section: Discussionunclassified
“…Although ERT and HSCT are able to mitigate many symptoms of MPS, it is important to emphasize that they are only treatments and not cures. Certain tissues remain resistant to treatment and continue to manifest GAG storage [3,5,6,7]. In addition, with treatment, more MPS patients are now surviving into adulthood and face a different set of potentially life-threatening disease complications.…”
Section: Introductionmentioning
confidence: 99%